Financial Performance - Operating revenue rose by 21.80% to CNY 414,357,193.77 year-on-year[7] - Net profit attributable to shareholders increased by 37.48% to CNY 68,679,647.12 compared to the same period last year[7] - Basic earnings per share increased by 24.73% to CNY 0.116[7] - The weighted average return on net assets rose by 0.39 percentage points to 3.24%[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses grew by 32.73%, driven by increased marketing efforts[8] - Total operating revenue increased to ¥414,357,193.77 from ¥340,185,717.86, representing a growth of approximately 21.8% year-over-year[31] - Net profit for the period was ¥69,419,928.31, up from ¥50,531,812.71, reflecting a growth of approximately 37.4% year-over-year[32] - Earnings per share (EPS) increased to ¥0.116 from ¥0.093, marking a rise of approximately 24.7% year-over-year[32] - Operating profit for the period was ¥76,640,987.21, compared to ¥57,219,557.68, reflecting an increase of about 34.1% year-over-year[32] - The company reported a total profit of ¥82,651,088.31, up from ¥60,673,748.55, representing a growth of approximately 36.2% year-over-year[32] Cash Flow - Net cash flow from operating activities improved significantly, reaching CNY 43,369,023.16, compared to a negative cash flow in the previous year[7] - The net cash flow from operating activities improved to 43,369,023.16, compared to a negative cash flow of -55,496.87 in the previous period[19] - The net cash flow from financing activities surged by 689.37% to 80,414,120.81, driven by increased loan receipts and reduced loan repayments[19] - The net cash flow from financing activities improved to CNY 80,414,120.81, compared to CNY 20,724,439.63 in the same quarter last year, reflecting a growth of over 287%[38] - Cash inflow from operating activities totaled ¥437,528,747.79, compared to ¥355,702,740.94 in the previous period, indicating an increase of about 23.0% year-over-year[35] - The cash flow from sales of goods and services was CNY 391,315,967.43, up from CNY 318,678,163.53, reflecting a growth of about 23%[37] Assets and Liabilities - Total assets increased by 7.37% to CNY 3,201,286,204.54 compared to the end of the previous year[7] - Current assets totaled CNY 1,653,002,599.87, compared to CNY 1,562,833,169.14, reflecting an increase of about 5.79%[25] - Non-current assets rose to CNY 1,548,283,604.67 from CNY 1,418,688,224.55, marking a growth of approximately 9.14%[25] - Total liabilities amounted to CNY 1,012,618,491.27, an increase from CNY 869,349,933.66, indicating a rise of around 16.43%[26] - Current liabilities reached CNY 898,862,140.85, up from CNY 756,718,164.34, which is an increase of approximately 18.77%[26] - Owner's equity totaled CNY 2,188,667,713.27, compared to CNY 2,112,171,460.03, reflecting a growth of about 3.62%[27] - Cash and cash equivalents increased to CNY 350,888,247.41 from CNY 276,430,311.39, representing a growth of approximately 27.0%[28] Shareholder Information - The total number of shareholders reached 44,955 by the end of the reporting period[12] - The largest shareholder, Henan Lingrui Group Co., Ltd., holds 20.57% of the shares, with 121,817,898 shares[12] Investment Activities - The company signed a cooperation agreement with Henan Xinhui Construction Investment Group to develop a real estate project, establishing a new subsidiary with a land valuation of 190 million RMB[21] - The company plans to transfer 60% of its stake in the newly established real estate subsidiary for 114 million RMB, enhancing its strategic partnerships[21] - Total cash inflow from investment activities was CNY 532,084,965.82, compared to CNY 30,100,383.55 in the same period last year, indicating a substantial increase of over 1,669%[37] - The total cash outflow from investment activities was CNY 594,201,469.90, compared to CNY 84,977,552.74 in the previous year, indicating a significant increase of approximately 600%[37] - The cash outflow for purchasing fixed assets and intangible assets was CNY 114,197,399.90, compared to CNY 23,427,552.74 in the previous year, representing an increase of approximately 387%[37]
羚锐制药(600285) - 2017 Q1 - 季度财报